{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T06:06:44Z","timestamp":1788329204069,"version":"build-2803163510"},"reference-count":17,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":1095,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2012,9]]},"DOI":"10.1002\/hep.25696","type":"journal-article","created":{"date-parts":[[2012,3,5]],"date-time":"2012-03-05T23:27:09Z","timestamp":1330990029000},"page":"797-799","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":7,"title":["NS5A: A new target for antiviral drugs in the treatment of hepatitis C virus infection"],"prefix":"10.1097","volume":"56","author":[{"given":"Jose D.","family":"Debes","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Coleman I.","family":"Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"issue":"Suppl 1","key":"R1-2-20250207","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1111\/j.1478-3231.2008.01934.x","article-title":"The global burden of hepatitis C.","volume":"29","author":"Lavanchy","year":"2009","journal-title":"Liver Int"},{"key":"R3-2-20250207","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1016\/j.cld.2006.08.012","article-title":"Hepatitis C virus and liver transplantation.","volume":"10","author":"Verna","year":"2006","journal-title":"Clin Liver Dis"},{"key":"R4-2-20250207","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1136\/gut.2008.166348","article-title":"Gene expression and hepatitis C virus infection.","volume":"58","author":"Asselah","year":"2009","journal-title":"Gut"},{"key":"R5-2-20250207","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1186\/1743-422X-8-161","article-title":"An overview of HCV molecular biology, replication and immune responses.","volume":"8","author":"Ashfaq","year":"2011","journal-title":"Virol J"},{"key":"R6-2-20250207","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1016\/j.jhep.2010.04.015","article-title":"Hepatitis C virus replication cycle.","volume":"53","author":"Bartenschlager","year":"2010","journal-title":"J Hepatol"},{"key":"R7-2-20250207","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1038\/msb.2008.66","article-title":"Hepatitis C virus infection protein network.","volume":"4","author":"de Chassey","year":"2008","journal-title":"Mol Syst Biol"},{"key":"R8-2-20250207","doi-asserted-by":"crossref","first-page":"12675","DOI":"10.1074\/jbc.M008329200","article-title":"Modulation of cell growth by the hepatitis C virus nonstructural protein NS5A.","volume":"276","author":"Arima","year":"2001","journal-title":"J Biol Chem"},{"key":"R9-2-20250207","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.pep.2004.05.005","article-title":"Purification and characterization of hepatitis C virus nonstructural protein 5A expressed in Escherichia coli.","volume":"37","author":"Huang","year":"2004","journal-title":"Protein Expr Purif"},{"key":"R10-2-20250207","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1128\/JVI.01070-10","article-title":"Hepatitis C virus NS2 protein serves as a scaffold for virus assembly by interacting with both structural and nonstructural proteins.","volume":"85","author":"Ma","year":"2011","journal-title":"J Virol"},{"key":"R11-2-20250207","doi-asserted-by":"crossref","first-page":"2485","DOI":"10.1099\/vir.0.80204-0","article-title":"Hepatitis C virus NS5A: tales of a promiscuous protein.","volume":"85","author":"Macdonald","year":"2004","journal-title":"J Gen Virol"},{"key":"R13-2-20250207","doi-asserted-by":"crossref","first-page":"263","DOI":"10.3350\/kjhep.2010.16.3.263","article-title":"New treatments for chronic hepatitis C.","volume":"16","author":"Jang","year":"2010","journal-title":"Korean J Hepatol"},{"key":"R14-2-20250207","doi-asserted-by":"crossref","first-page":"1827","DOI":"10.1056\/NEJMoa0806104","article-title":"Telaprevir with peginterferon and ribavirin for chronic HCV genotype 1 infection.","volume":"360","author":"McHutchison","year":"2009","journal-title":"N Engl J Med"},{"key":"R15-2-20250207","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1016\/S0140-6736(10)60934-8","article-title":"Efficacy of boceprevir, an NS3 protease inhibitor, in combination with peginterferon alfa2b and ribavirin in treatmentnaive patients with genotype 1 hepatitis C infection (SPRINT1): an openlabel, randomised, multicentre phase 2 trial.","volume":"376","author":"Kwo","year":"2010","journal-title":"Lancet"},{"key":"R16-2-20250207","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1038\/nature08960","article-title":"Chemical genetics strategy identifies an HCV NS5A inhibitor with a potent clinical effect.","volume":"465","author":"Gao","year":"2010","journal-title":"Nature"},{"key":"R18-2-20250207","doi-asserted-by":"crossref","first-page":"7312","DOI":"10.1128\/JVI.00253-11","article-title":"Distinct functions of NS5A in hepatitis C virus RNA replication uncovered by studies with the NS5A inhibitor BMS790052.","volume":"85","author":"Fridell","year":"2011","journal-title":"J Virol"},{"key":"R19-2-20250207","doi-asserted-by":"crossref","first-page":"1956","DOI":"10.1002\/hep.24609","article-title":"Multiple ascending dose study of BMS790052, an NS5A replication complex inhibitor, in patients infected with hepatitis C virus genotype 1.","volume":"54","author":"Nettles","year":"2011","journal-title":"HEPATOLOGY"},{"key":"R20-2-20250207","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1056\/NEJMoa1104430","article-title":"Preliminary study of two antiviral agents for hepatitis C genotype 1.","volume":"366","author":"Lok","year":"2012","journal-title":"New Engl J Med"}],"container-title":["Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fhep.25696","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.lww.com\/01515467-201209000-00002","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,7]],"date-time":"2025-02-07T16:51:59Z","timestamp":1738947119000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/01515467-201209000-00002"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,9]]},"references-count":17,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2012]]}},"URL":"https:\/\/doi.org\/10.1002\/hep.25696","relation":{},"ISSN":["0270-9139"],"issn-type":[{"value":"0270-9139","type":"print"}],"subject":[],"published":{"date-parts":[[2012,9]]}}}